TrialJournal of thrombosis and thrombolysis2018

Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial.

Megan K Yee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.